Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]INSYS Therapeutics Inc"
Count: 49
Selected: 0
| NCT ID | Title |
|---|
| NCT03827642 | A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers | ||
| NCT03827629 | A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers | ||
| NCT03254459 | Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain | ||
| NCT02551731 | Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms | ||
| NCT02318602 | Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder | ||
| NCT01188408 | Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer | ||
| NCT02915978 | Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain | ||
| NCT02318563 | Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome | ||
| NCT02318537 | Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome | ||
| NCT02138409 | Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting | ||
| NCT02634788 | Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain | ||
| NCT02310581 | Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain | ||
| NCT02137525 | Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain | ||
| NCT02324673 | Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders | ||
| NCT02641340 | Fentanyl Sublingual Spray in Opioid Naive Participants | ||
| NCT02604992 | Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers | ||
| NCT02576353 | Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects | ||
| NCT02477267 | Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers | ||
| NCT01832974 | Possible New Therapy for Advanced Cancer | ||
| NCT02138396 | Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions | ||
| NCT00024687 | Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses | ||
| NCT00024674 | Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days | ||
| NCT00024570 | Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma | ||
| NCT00378235 | Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma | ||
| NCT02094599 | A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users | ||
| NCT00538850 | Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain | ||
| NCT00538863 | Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain | ||
| NCT00956254 | Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis | ||
| NCT01780233 | Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv) | ||
| NCT01186731 | Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT01190982 | Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer | ||
| NCT01448772 | Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions | ||
| NCT01151384 | Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors | ||
| NCT00100672 | Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer | ||
| NCT00100139 | Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer | ||
| NCT00089427 | IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma | ||
| NCT00080418 | Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer | ||
| NCT00046540 | Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer | ||
| NCT00076986 | The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | ||
| NCT00064779 | Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma | ||
| NCT00041587 | Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma | ||
| NCT00024557 | Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients | ||
| NCT00024492 | Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer | ||
| NCT00024661 | Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors | ||
| NCT00024648 | Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies | ||
| NCT02514252 | Sublingual Fentanyl for the Management of Breakthrough Pain | ||
| NCT02751359 | Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers | ||
| NCT02597478 | Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea | ||
| NCT02902081 | Cannabidiol and Emotional Stimuli |
